Aphria (APH) has notable insider selling

Aphria (:APH)

Cole Caciavillani, a Senior Officer, Director and 10% Holder executive, disposed 97,700 Common Shares on a direct ownership basis at prices ranging from $10.000 and $10.110 through the public market between May 4th, 2018 and May 7th, 2018. This represents a $984,700 divestment of the company's shares and an account share holdings change of -1.6%.

Philip Waddington, a Director, disposed 1,397 Common Shares on a direct ownership basis at a price of $9.850 through the public market on May 7th, 2018. This represents a $13,760 divestment of the company's shares and an account share holdings change of -4.4%.

Aphria Inc., formerly Black Sparrow Capital Corp., is a Canada-based company, which is engaged in producing and selling medical marijuana through retail sales and wholesale channels. The Company's retail sales are primarily sold through the Company's online store, as well as telephone orders. Its wholesale shipments are sold to other Medical Purposes Regulations (MMPR) Licensed Producers. It offers medical cannabis of various strains, including Kusawa, Tamaracouta, Panache, Churchill and Iroquois. The Company is also engaged in the research and development, and commercial production of cannabis oil. Its cannabis oil products will include Champlain, Rideau and Capilano. Its cannabis oil products will be available in approximately 60 milliliter bottles. Its subsidiaries include Pure Natures Wellness Inc., which is engaged in producing and selling medical marijuana, and Cannway Pharmaceuticals Ltd., which specializes in providing support services to veterans and first responders.